Lewis NM, Self WH, Gaglani M, Ginde AA, et al. Effectiveness of the Ad26.COV2.S (Johnson & Johnson) COVID-19 Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States. Clin Infect Dis 2022 Jun 8. pii: 6604454. doi: 10.1093.
PMID: 35675695